Loading organizations...
§ Private Profile · Houston, TX, USA
Biopharmaceutical company developing novel oncology products for cancer.
ImmunoMet Therapeutics has raised $27.2M across 4 funding rounds.
ImmunoMet Therapeutics has raised $27.2M in total across 4 funding rounds.
ImmunoMet Therapeutics has raised $27.2M in total across 4 funding rounds.
ImmunoMet Therapeutics's investors include Sungwuk Kim, G.N. Tech Venture Capital, InterVest, Mirae Asset Venture Investment, NHN Ventures, SL Investment, Jae Joon Kim, Aju Tech, Metavest Capital.
ImmunoMet Therapeutics has raised $27.2M across 4 funding rounds. Most recently, it raised $7.0M Other Equity in February 2021.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 8, 2021 | $7M Venture Round | — | — | Announced |
| Sep 1, 2018 | $10M Series B | — | — | Announced |
| Mar 7, 2017 | $5M Series B | — | Sungwuk KIM, G.n. Tech Venture Capital, Intervest, Mirae Asset Venture Investment, NHN Ventures, SL Investment | Announced |
| Mar 8, 2016 | $5.2M Series A | JAE Joon KIM | AJU Tech, G.n. Tech Venture Capital, Metavest Capital | Announced |